Paula Ravin is a Neurology physician. OpenAlex indexes 22 publications with 882 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Medical Plaza
Department Of Neurology B 200
Los Angeles, CA 90025
Telephone
310-206-3183Provider last certified this registry record 25 Dec 2023.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- MDD US Operations, LLCProgram year20256 payments
- Amneal Pharmaceuticals LLCProgram year202516 payments
- ABBVIE INC.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
90.8%Neuromuscular Blocker90.7%Onabotulinumtoxina100%Part B, office-administered≥31 patientsgamma-Aminobutyric Acid-ergic Agonist0.1%Baclofen100%Part D<11 patientsNervous system
8.5%Aromatic Amino Acid Decarboxylation Inhibitor3.5%Rytary48%Carbidopa-Levodopa46%Carbidopa-Levodopa Er6%Part D≥85 patientsBenzodiazepine0.8%Clonazepam52%Lorazepam30%Alprazolam11%Diazepam8%Part D<11 patients+ 17 more classes in this area
Cardiovascular
0.3%Beta blocker0.3%Propranolol Hcl57%Propranolol Hcl Er43%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Multi-parametric analysis assists in STN localization in Parkinson's patients
Journal of the Neurological Sciences
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”